USD/JPY: Broad dollar weakness skews the risk to the downside
|
The USD/JPY pair is easing from a daily high of 107.91, now trading near its weekly low at 107.65 as economic reopenings and hopes for a coronavirus vaccine lift the market’s mood, weighing on the greenback, FXStreet’s analyst Valeria Bednarik reports.
Key quotes
“A US biotechnology company, Novavax, announced that it has started human trials of a COVID-19 vaccine in Australia, and expected results from the trial in July. Up to today, there are a dozen different promising vaccines being studied around the world.”
“Japan published its Corporate Services Price Index for April, which resulted in 1.% YoY, worse than the 1.9% expected. The All Industry Activity Index for March declined by 3.8%, also missing the market’s expectations.”
“Given the broad dollar’s on a risk-on mood, the risk for the pair turned to the downside, with further declines expected on a break below 107.30, the immediate support level.”
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.